Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of Emergency Medicine Année : 2018

Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial

(1) , (2) , , (3) , (4) , (5) , (6) , (7, 8, 9, 10) , (11) , (12, 13, 14) , (15) , (16, 17) , , (5) , (11) , , (5, 18) , (19, 15) , (20) , (21) , (5) , (1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Elinor Baker
  • Fonction : Auteur
Laurence Bouillet
Alain Sobel
  • Fonction : Auteur
Tomislav Petrovic
  • Fonction : Auteur

Résumé

STUDY OBJECTIVE: Hereditary angioedema is a rare disease associated with unpredictable, recurrent attacks of potentially life-threatening edema. Management of severe attacks is currently suboptimal because emergency medical teams are often unaware of new specific treatments. The objective of this trial is to test whether a dedicated national telephone care-management strategy would reduce resource use during severe hereditary angioedema attacks.

METHODS: We conducted a cluster-randomized multicenter prospective trial of patients with a documented diagnosis of hereditary angioedema (type I, II or FXII hereditary angioedema). Participants were enrolled between March 2013 and June 2014 at 8 participating reference centers. The randomized units were the reference centers (clusters). Patients in the intervention arm were given a national free telephone number to call in the event of a severe attack. Emergency physicians in the SOS-hereditary angiœdema (SOS-HAE) call center were trained to advise or prescribe specific treatments. The primary outcome was number of admissions for angioedema attacks. Economic evaluation was also performed.

RESULTS: We included 100 patients in the SOS-HAE group and 100 in the control group. During the 2 years, there were 2,368 hereditary angioedema attacks among 169 patients (85%). Mean number of hospital admissions per patient in the 2-year period was significantly greater in the usual-practice group (mean 0.16 [range 0 to 2] versus 0.03 [range 0 to 1]); patient risk difference was significant: -0.13 (95% confidence interval -0.22 to -0.04; P=.02). Probabilistic sensitivity graphic analysis indicated a trend toward increased quality-adjusted life-years in the SOS-HAE group.

CONCLUSION: A national dedicated call center for management of severe hereditary angioedema attacks is associated with a decrease in hospital admissions and may be cost-effective if facilities and staff are available to deliver the intervention alongside existing services.

Fichier non déposé

Dates et versions

hal-02616882 , version 1 (25-05-2020)

Identifiants

Citer

Bernard Floccard, Gisele Kanny, Elinor Baker, Ludovic Martin, Eric Vicaut, et al.. Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial. Annals of Emergency Medicine, 2018, 72 (2), pp.194-203.e1. ⟨10.1016/j.annemergmed.2018.01.053⟩. ⟨hal-02616882⟩
48 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More